A hypothetical investment strategy, involving investing $100,000 in January into the S&P 500's top-performing stock and re-investing monthly into each subsequent month's best performer, would have yielded $12.7 million by August. Vaccine maker Moderna (MRNA) was cited as a top performer in August.